Xeris Biopharma Holdings, Inc. XERS

Set alert

Price alert · XERS

All alert types
10.42 USD +0.25 +2.44%

As of Nov 3, 10:27 AM ET

Bid
10.41 × 2
Ask
10.44 × 1
10.17 Day range 10.56
5.25 52-week range 11.42
YTD
+32.72%
1 year
+5.23%
Open
10.17
Prev close
10.17
Mkt cap
1.90B
Vol
273.73K
Avg vol
2.35M
EPS
-0.10
P/E
0.00
Div yield
0.00%
More statistics
Low
10.17
High
10.56
Forward P/E
51.71
Beta
0.84
Short ratio
2.46
Inst. own
61.87%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
9.31
200-d avg
7.50
1y target
12.86

5D chart

Chart tools
Interval

Signals (88)
NameTimeAgo
SMA: BearishNov 3, 10:15 AM12 minutes ago
SMA: BullishNov 3, 10:10 AM17 minutes ago
SMA: BearishNov 3, 10:05 AM22 minutes ago
SMA: BullishNov 3, 9:30 AM57 minutes ago
SMA: BullishNov 3, 9:30 AM57 minutes ago
MACD: Buy SignalNov 3, 9:30 AM57 minutes ago
RSI: OverboughtNov 3, 9:30 AM57 minutes ago
SMA: BearishNov 2, 3:55 PM18 hours ago
MACD: Sell SignalNov 2, 3:55 PM18 hours ago
SMA: BearishNov 2, 3:50 PM18 hours ago
SMA: BullishNov 2, 2:40 PM19 hours ago
MACD: Buy SignalNov 2, 2:10 PM20 hours ago
SMA: BearishNov 2, 1:10 PM21 hours ago
MACD: Sell SignalNov 2, 1:10 PM21 hours ago
SMA: BearishNov 2, 1:00 PM21 hours ago
SMA: BullishNov 2, 11:50 AM22 hours ago
SMA: BullishNov 2, 11:05 AM23 hours ago
MACD: Buy SignalNov 2, 11:05 AM23 hours ago
SMA: BearishNov 2, 10:50 AM23 hours ago
SMA: BullishNov 2, 10:45 AM23 hours ago

Newest 20 of 88.

Revenue & Expenses

Revenue → Gross Profit: $238.43MGross Profit → Net Income: $554.00KGross Profit → Selling, General & Admin: $182.37MGross Profit → Research & Development: $31.16MRevenue → Cost of Revenue: $53.41MGross Profit → Other Expenses: $24.34MGross Profit$238.43MCost of Revenue$53.41MNet Income$554.00KSelling, General & Admin$182.37MResearch & Development$31.16MOther Expenses$24.34MRevenue$291.85M

Latest period ending Dec 31, 2025 · select a line to chart its full history

XERS annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
291.85M203.07M163.91M110.25M49.59M
249.28M166.24M135.27M87.61M36.27M
24.90M-33.65M-44.01M-81.94M-115.16M
554.00K-54.84M-62.26M-94.66M-122.72M
XERS annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
111.04M71.62M67.45M121.97M67.27M
383.53M323.06M322.60M344.52M304.36M
369.84M352.68M329.38M299.33M209.13M
258.10M271.45M229.19M198.06M88.07M
13.69M-29.61M-6.78M45.19M95.23M
XERS annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
28.63M-36.98M-47.02M-102.89M-95.53M
-696.00K4.88M-6.00M34.46M97.96M
11.39M36.17M-1.61M127.47M27.25M
-696.00K-868.00K-2.26M-524.00K-1.08M
39.32M4.07M-54.64M59.04M29.67M